Pulsed alexandrite laser for treatment of melasma in Asian patients

References

• Sanchez NP, Pathak MA, Sato S. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol. 1981;4:698–709.
   PubMed Web of Science ®Google Scholar
• Sivayathorn A. Melasma in orientals. Clin Drug Invest. 1995;10(Suppl. 2):34–40.
   Google Scholar
• Ortonne JP, Arellano I, Berneburg M, Cestari T, Chan H, Grimes P, et al. A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol. 2009;23:1254–1262.
   PubMed Web of Science ®Google Scholar
• Grimes PE. Melasma: etiologic and therapeutic considerations. Arch Dermatol. 1995;131:1453–1457.
   PubMed Web of Science ®Google Scholar
• Im S, Kim J, On WY, Kang WH. Increased expression of a-melanocyte-stimulating hormone in the lesional skin of melasma. Br J Dermatol. 2007;146:165–167.
   Google Scholar
• Handel AC, Miot LD, Miot HA. Melasma: a clinical and epidemiological review. An Bras Dermatol. 2014;89:771–782.
   PubMed Web of Science ®Google Scholar
• Lieberman R, Moy L. Estrogen receptor expression in melasma: results from facial skin of affected patients. J Drugs Dermatol. 2008;7:463–465.
   PubMed Web of Science ®Google Scholar
• Kim EH, Kim YC, Lee E-S, Kang HY. The vascular characteristics of melasma. J Dermatol Sci. 2007;46:111–116.
   PubMed Web of Science ®Google Scholar
• Rostami Mogaddam M, Iranparvar Alamdari M, Maleki N, Safavi Ardabili N, Abedkouhi S. Evaluation of autoimmune thyroid disease in melasma. J Cosmet Dermatol. 2015;14:167–171.
   PubMed Web of Science ®Google Scholar
• Rivas S, Pandya AG. Treatment of melasma with topical agents, peels and lasers: an evidence-based review. Am J Clin Dermatol. 2013;14:359–376.
   PubMed Web of Science ®Google Scholar
• Ball Arefiev KL, Hantash BM. Advances in the treatment of melasma: a review of the recent literature. Dermatol Surg. 2012;38:971–984.
   PubMed Web of Science ®Google Scholar
• Vachiramon V, Sirithanabadeekul P, Sahawatwong S. Low-fluence Q-switched Nd: YAG 1064-nm laser and intense pulsed light for the treatment of melasma. J Eur Acad Dermatol Venereol. 2015;29:1339–1346.
   PubMed Web of Science ®Google Scholar
• Yun WJ, Moon HR, Lee MW, Choi JH, Chang SE. Combination treatment of low-fluence 1,064-nm Q-switched Nd: YAGlaser with novel intense pulse light in Korean melasma patients: a prospective, randomized, controlled trial. Dermatol Surg. 2014;40:842–850.
   PubMed Web of Science ®Google Scholar
• Zhou X, Gold MH, Lu Z, Li Y. Efficacy and safety of Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser treatment of melasma. Dermatol Surg. 2011;37:962–970.
   PubMed Web of Science ®Google Scholar
• Mun JY, Jeong SY, Kim JH, Han SS, Kim IH. A low fluence Q-switched Nd: YAGlaser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis. J Electron Microsc (Tokyo). 2011;60:11–18.
   PubMedGoogle Scholar
• Kim JE, Chang SE, Yeo UC, Haw S, Kim IH. Histopathological study of the treatment of melasma lesions using a low-fluence Q-switched 1064-nm neodymium: yttrium-aluminium-garnetlaser. Clin Exp Dermatol. 2013;38:167–171.
   PubMed Web of Science ®Google Scholar
• Jang YH, Park JY, Park YJ, Kang HY. Changes in melanin and melanocytes in mottled hypopigmentation after low-fluence 1,064-nm Q-switched Nd: YAGlaser treatment for melasma. Ann Dermatol. 2015;27:340–342.
   PubMed Web of Science ®Google Scholar
• Fabi SG, Friedmann DP, Niwa Massaki AB, Goldman MP. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma. Lasers Surg Med. 2014;46:531–537.
   PubMed Web of Science ®Google Scholar
• Li YH, Chen JZ, Wei HC, Wu Y, Liu M, Xu YY, et al. Efficacy and safety of intense pulsed light in treatment of melasma in Chinese patients. Dermatol Surg. 2008;34:693–700.
   PubMed Web of Science ®Google Scholar
• Yamashita T, Negishi K, Hariya T, Kunizawa N, Ikuta K, Yanai M, et al. Intense pulsed light therapy for superficial pigmented lesions evaluated by reflectance-mode confocal microscopy and optical coherence tomography. J Invest Dermatol. 2006;126:2281–2286.
   PubMed Web of Science ®Google Scholar
• Passeron T, Fontas E, Kang HY, Bahadoran P, Lacour JP, Ortonne JP. Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study. Arch Dermatol. 2011;147:1106–1108.
   PubMedGoogle Scholar
• Lee YB, Shin JY, Cheon MS, Oh ST, Cho BK, Park HJ. Photorejuvenation using long-pulsed alexandrite and long-pulsed neodymium: yttrium-aluminum-garnetlasers: a pilot study of clinical outcome and patients’ satisfaction in Koreans. J Dermatol. 2012;39:425–429.
   PubMed Web of Science ®Google Scholar
• Lee YB, Kang NH, Eun YS, Cheon MS, Kim KM, Cho BK, et al. Effects of long-pulsed 1,064-nm neodymium-doped yttrium aluminum garnet laser on dermal collagen remodeling in hairless mice. Dermatol Surg. 2012;38:985–992.
   PubMed Web of Science ®Google Scholar
• Choi CP, Yim SM, Seo SH, Ahn HH, Kye YC, Choi JE. Retreatment using a dual mode of low-fluence Q-switched and long-pulse Nd: YAGlaser in patients with melasma aggravation after previous therapy. J Cosmet Laser Ther. 2015;17:129–134.
   PubMed Web of Science ®Google Scholar
• Lee MC, Chang CS, Huang YL, Chang SL, Chang CH, Lin YF, et al. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd: YAGlaser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study. Lasers Med Sci. 2015;30:159–163.
   PubMed Web of Science ®Google Scholar